비피도

238200KOSDAQ기타 식품 제조업

58.8 / 100

Reference Date: 2026-07-24

Financial Score18.5 / 40

News Sentiment21.3 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Roughly flat over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Bifido is a company that produces probiotic raw materials and finished products based on physiologically active bifidobacteria strains discovered by Professor Ji Geun-eok in 1994. It holds FDA NDI and GRAS certifications and utilizes the MAP platform technology to develop functional probiotics and microbiome-based therapeutics. The company is also expanding into B2C markets through the development of individually recognized probiotic raw materials.

Number of Employees

102people

Average Salary

42.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 12.074.0Point

PBR

0.45Industry Average 0.544.0Point

In line with industry avg

ROE

-0.42Industry Average 2.720.0Point

Well below industry avg

Debt Ratio

1.00Industry Average 11.918.0Point

Half of industry avg (excellent)

Trend 2023~20252.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲12.8% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼537.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -3.1% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Positive
"프로바이오틱스로 비만 잡는다"…헥토헬스케어, 식약처 개별인정
비피도 관련 헥토헬스케어의 체지방 감소 기능성 유산균 승인으로 긍정적인 시장 반응 예상.
Positive
레이델, 프리미엄 유산균 담은 '장건강 밸런스' 출시
레이델의 새로운 장건강 밸런스 출시로 비피도 관련 긍정적인 시장 반응 예상.

Detailed Momentum

52-week position1.0Point

Near 52w low (13%, downtrend)

Current 2,500Won52-week high 4,33552-week low 2,215

1-month return3.0Point

1m -0.99% (flat)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0